Citigroup has decided to maintain its Buy rating of BeiGene (NASDAQ:BGNE) and raise its price target from $285.00 to $290.00.
Shares of BeiGene are trading down 2.84% over the last 24 hours, at $187.37 per share.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased